AAAAAA

   
Results: 1-12 |
Results: 12
Fas/APO-1 promoter polymorphism is not associated with non-melanoma skin cancer
Authors: Nelson, HH Kelsey, KT Bronson, MH Mott, LA Karagas, MR
Citation: Hh. Nelson et al., Fas/APO-1 promoter polymorphism is not associated with non-melanoma skin cancer, CANC EPID B, 10(7), 2001, pp. 809-810
Two-stage methods for the analysis of pooled data
Authors: Stukel, TA Demidenko, E Dykes, J Karagas, MR
Citation: Ta. Stukel et al., Two-stage methods for the analysis of pooled data, STAT MED, 20(14), 2001, pp. 2115-2130
Bacteremia due to Mycobacterium tuberculosis or M. bovis, Bacille Calmette-Guerin (BCG) among HIV-positive children and adults in Zambia
Authors: Waddell, RD Lishimpi, K von Reyn, CF Chintu, C Baboo, KS Kreiswirth, B Talbot, EA Karagas, MR
Citation: Rd. Waddell et al., Bacteremia due to Mycobacterium tuberculosis or M. bovis, Bacille Calmette-Guerin (BCG) among HIV-positive children and adults in Zambia, AIDS, 15(1), 2001, pp. 55-60
Non-melanoma skin cancers and glucocorticoid therapy
Authors: Karagas, MR Cushing, GL Greenberg, ER Mott, LA Spencer, SK Nierenberg, DW
Citation: Mr. Karagas et al., Non-melanoma skin cancers and glucocorticoid therapy, BR J CANC, 85(5), 2001, pp. 683-686
Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study
Authors: Karagas, MR Stukel, TA Morris, JS Tosteson, TD Weiss, JE Spencer, SK Greenberg, ER
Citation: Mr. Karagas et al., Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study, AM J EPIDEM, 153(6), 2001, pp. 559-565
Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis
Authors: Waddell, RD Chintu, C Lein, AD Zumla, A Karagas, MR Baboo, KS Habbema, JDF Tosteson, ANA Morin, P Tvaroha, S Arbeit, RD Mwinga, A von Reyn, CF
Citation: Rd. Waddell et al., Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis, CLIN INF D, 30, 2000, pp. S309-S315
Racial differences in pancreatic cancer: Comparison of survival and histologic types of pancreatic carcinoma in Asians, Blacks, and Whites in the United States
Authors: Longnecker, DS Karagas, MR Tosteson, TD Mott, LA
Citation: Ds. Longnecker et al., Racial differences in pancreatic cancer: Comparison of survival and histologic types of pancreatic carcinoma in Asians, Blacks, and Whites in the United States, PANCREAS, 21(4), 2000, pp. 338-343
Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma
Authors: Lichter, MD Karagas, MR Mott, LA Spencer, SK Stukel, TA Greenberg, ER
Citation: Md. Lichter et al., Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma, ARCH DERMAT, 136(8), 2000, pp. 1007-1011
Measurement of low levels of arsenic exposure: A comparison of water and toenail concentrations
Authors: Karagas, MR Tosteson, TD Blum, J Klaue, B Weiss, JE Stannard, V Spate, V Morris, JS
Citation: Mr. Karagas et al., Measurement of low levels of arsenic exposure: A comparison of water and toenail concentrations, AM J EPIDEM, 152(1), 2000, pp. 84-90
Fracture risk in the US Medicare population
Authors: Barrett, JA Baron, JA Karagas, MR Beach, ML
Citation: Ja. Barrett et al., Fracture risk in the US Medicare population, J CLIN EPID, 52(3), 1999, pp. 243-249
Increase in incidence rates of basal cell and squamous cell skin cancer inNew Hampshire, USA
Authors: Karagas, MR Greenberg, ER Spencer, SK Stukel, TA Mott, LA
Citation: Mr. Karagas et al., Increase in incidence rates of basal cell and squamous cell skin cancer inNew Hampshire, USA, INT J CANC, 81(4), 1999, pp. 555-559
Arsenic occurrence in New Hampshire drinking water
Authors: Peters, SC Blum, JD Klaue, B Karagas, MR
Citation: Sc. Peters et al., Arsenic occurrence in New Hampshire drinking water, ENV SCI TEC, 33(9), 1999, pp. 1328-1333
Risultati: 1-12 |